Corient Private Wealth’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAT
PCM
Corient Private Wealth's BCAT Position: Q1 2026 in Review
Corient Private Wealth reduced its BlackRock Capital Allocation Term Trust (BCAT) stake by 50% in Q1 2026, selling an estimated $413K and leaving 28,059 shares worth $28.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2774.
Corient Private Wealth first reported a position in BCAT in Q1 2024 and has held it in 9 quarters since. The position peaked at $795K in Q4 2025. 100 funds tracked by Wall St. Rank hold BCAT as of Q1 2026.
- Corient Private Wealth held 28,059 shares of BlackRock Capital Allocation Term Trust worth $28.6K as of Q1 2026.
- Corient Private Wealth sold 28,059 BlackRock Capital Allocation Term Trust shares in Q1 2026, an estimated $413K.
- BlackRock Capital Allocation Term Trust made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #2774 holding.
- Corient Private Wealth first reported a position in BlackRock Capital Allocation Term Trust in Q1 2024 and has held it in 9 quarters since.
- Corient Private Wealth's BlackRock Capital Allocation Term Trust position peaked at $795K in Q4 2025.
- 100 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q1 2026.
Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.